Difference between revisions of "Lopatina T, et al. Front. Oncol. (2016) cited as Ref 526 in DOI: 10.1038/s41392-020-0110-5 (Q9789)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 125-, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Kholia S, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Kholia S | ||
| Property / Fourth Author string: Kholia S / rank | |||
| + | Normal rank | ||
Revision as of 13:50, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Lopatina T, et al. Front. Oncol. (2016) cited as Ref 526 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Lopatina T
0 references
Gai C
0 references
Deregibus MC
0 references
2016
0 references
Front. Oncol.
0 references
6
0 references
Cross talk between cancer and mesenchymal stem cells through extracellular vesicles carrying nucleic acids. (English)
0 references
125-
0 references
Kholia S
0 references
